UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3633) 3633
science & technology (3443) 3443
life sciences & biomedicine (3351) 3351
male (2451) 2451
cardiotonic agents - therapeutic use (2077) 2077
female (1904) 1904
cardiovascular system & cardiology (1439) 1439
animals (1416) 1416
cardiac & cardiovascular systems (1388) 1388
biological and medical sciences (1358) 1358
middle aged (1339) 1339
medical sciences (1323) 1323
aged (1166) 1166
cardiotonic agents (1157) 1157
cardiotonic agents - pharmacology (1080) 1080
cardiotonic agents - adverse effects (1057) 1057
heart failure - drug therapy (1047) 1047
cardiotonic agents - administration & dosage (893) 893
heart failure (830) 830
abridged index medicus (824) 824
pharmacology. drug treatments (777) 777
cardiovascular system (741) 741
pharmacology & pharmacy (717) 717
adult (711) 711
heart (701) 701
treatment outcome (683) 683
rats (549) 549
risk factors (498) 498
hemodynamics - drug effects (486) 486
heart failure - physiopathology (484) 484
cardiology (440) 440
time factors (410) 410
general & internal medicine (396) 396
cardiac glycosides (395) 395
cardiology. vascular system (363) 363
care and treatment (358) 358
prospective studies (346) 346
drug therapy (340) 340
dobutamine (338) 338
medicine & public health (331) 331
health aspects (329) 329
dose-response relationship, drug (328) 328
mortality (317) 317
surgery (317) 317
heart rate - drug effects (313) 313
analysis (311) 311
cardiovascular (304) 304
research (304) 304
aged, 80 and over (292) 292
electrocardiography (286) 286
retrospective studies (280) 280
echocardiography (278) 278
blood pressure - drug effects (274) 274
heart - drug effects (271) 271
double-blind method (268) 268
cardiac patients (267) 267
myocardium - metabolism (265) 265
heart attacks (252) 252
infusions, intravenous (248) 248
myocardial contraction - drug effects (248) 248
disease models, animal (241) 241
medicine, general & internal (241) 241
myocardium - pathology (239) 239
anesthesiology (237) 237
rats, sprague-dawley (234) 234
heart failure - mortality (233) 233
cardiovascular disease (230) 230
mice (230) 230
prognosis (230) 230
heart diseases (227) 227
pyridazines - therapeutic use (225) 225
peripheral vascular disease (224) 224
vasodilator agents - therapeutic use (222) 222
drug therapy, combination (217) 217
ischemia (217) 217
coronary heart disease (214) 214
follow-up studies (207) 207
physiological aspects (202) 202
rats, wistar (201) 201
myocardial infarction (197) 197
digoxin (196) 196
digoxin - adverse effects (194) 194
myocytes, cardiac - drug effects (194) 194
rodents (192) 192
drug interactions (191) 191
hydrazones - therapeutic use (191) 191
apoptosis (190) 190
digoxin - therapeutic use (188) 188
adolescent (186) 186
pediatrics (186) 186
dobutamine - adverse effects (183) 183
child (180) 180
physiology (179) 179
hemodynamics (178) 178
oxidative stress (178) 178
respiratory system (178) 178
ventricular function, left - drug effects (178) 178
randomized controlled trials as topic (177) 177
risk assessment (177) 177
cardiology and cardiovascular medicine (174) 174
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4520) 4520
German (73) 73
French (38) 38
Russian (35) 35
Spanish (35) 35
Japanese (34) 34
Portuguese (24) 24
Italian (13) 13
Chinese (11) 11
Dutch (11) 11
Polish (9) 9
Czech (7) 7
Hungarian (5) 5
Norwegian (4) 4
Turkish (4) 4
Danish (3) 3
Romanian (2) 2
Ukrainian (2) 2
Croatian (1) 1
Finnish (1) 1
Hebrew (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Arteriosclerosis, thrombosis, and vascular biology, ISSN 1079-5642, 09/2013, Volume 33, Issue 9, pp. 2252 - 2260
Journal Article
Journal of nephrology, ISSN 1121-8428, 12/2014, Volume 27, Issue 6, pp. 659 - 666
Nephrology | Phase I | Medicine & Public Health | Urology/Andrology | Hyperphosphatemia | Chronic kidney disease | Pharmacokinetics | Sucroferric oxyhydroxide | Life Sciences & Biomedicine | Urology & Nephrology | Science & Technology | Digoxin - adverse effects | Diuretics - pharmacokinetics | Chelating Agents - administration & dosage | Humans | Middle Aged | Half-Life | Male | Metabolic Clearance Rate | Angiotensin II Type 1 Receptor Blockers - pharmacokinetics | Warfarin - administration & dosage | Young Adult | Drug Interactions | Proton Pump Inhibitors - administration & dosage | Cardiotonic Agents - adverse effects | Diuretics - blood | Angiotensin II Type 1 Receptor Blockers - administration & dosage | Diuretics - administration & dosage | Risk Assessment | Furosemide - pharmacokinetics | Cardiotonic Agents - pharmacokinetics | Omeprazole - administration & dosage | Sucrose - adverse effects | Anticoagulants - adverse effects | Anticoagulants - blood | Cardiotonic Agents - administration & dosage | Models, Biological | Ferric Compounds - adverse effects | Losartan - administration & dosage | Diuretics - adverse effects | Furosemide - administration & dosage | Angiotensin II Type 1 Receptor Blockers - adverse effects | Anticoagulants - administration & dosage | Area Under Curve | Losartan - blood | Omeprazole - blood | Warfarin - adverse effects | Ferric Compounds - administration & dosage | Healthy Volunteers | Furosemide - adverse effects | Adult | Female | Proton Pump Inhibitors - blood | Digoxin - blood | Losartan - pharmacokinetics | Chelating Agents - adverse effects | Furosemide - blood | Sucrose - administration & dosage | Proton Pump Inhibitors - adverse effects | Drug Administration Schedule | Omeprazole - adverse effects | Omeprazole - pharmacokinetics | Models, Statistical | Digoxin - pharmacokinetics | Warfarin - pharmacokinetics | Proton Pump Inhibitors - pharmacokinetics | Digoxin - administration & dosage | Cardiotonic Agents - blood | Warfarin - blood | Losartan - adverse effects | Anticoagulants - pharmacokinetics | Angiotensin II Type 1 Receptor Blockers - blood | Drug Combinations | Index Medicus | Original
Journal Article